Further analysis suggests that HSP90 inhibition results in downregulation of the anti-apoptotic proteins MCL-1 and XIAP, but not BCL2, in CLL cells (Figure 4H). This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.